Release Date: June 8, 2021
Expiration Date: June 7, 2022
Target Audience: Cardiologists, cardiovascular clinicians, cardiac surgeons, vascular surgeons, internists, hospitalists, primary care physicians, fellows and residents in training, advanced practice nurses, nurses in cardiology and other medical professionals interested in cardiovascular medicine.
As a result of participation in this activity, participants should be able to:
Requirements for successful completion: Certificates are awarded upon successful completion (80% proficiency) of the post-test.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and Inova Heart and Vascular Institute. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Resource(s) for further study:
This CME activity is supported by an educational grants from Abbott Laboratories, Biosense Webster, Inc, Chiesi USA, Inc, Cytokinetics, Medtronic, Merck, Novartis, and Zoll.
This CME activity is supported by an exhibits from Abbott Laboratories, Abiomed, Amgen, AstraZeneca, BioTel Heart, Boston Scientific, CVRx, Edwards Lifesciences, Esperion Theapeutics, Inc, Gore & Associates, Impulse Dynamics, Janssen Pharmaceutical, Medtronic, and Pfizer. View the virtual exhibit hall (Links to an external site.).
Section #: 1510, 2220